Modafinil improves primary nocturnal enuresis in multiple sclerosis.
Carrieri
P B
PB
de Leva
M F
MF
Carrieri
M
M
Buongiorno
M
M
D000328:Adult; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002490:Central Nervous System / Q000187:drug effects / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D005221:Fatigue / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use; D008297:Male; D000077408:Modafinil; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D053206:Nocturnal Enuresis / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D012680:Sensitivity and Specificity; D012890:Sleep / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome; D014851:Wakefulness / Q000187:drug effects / Q000502:physiology
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000077408:Modafinil